Dupilumab efficacy in patients with type 2 asthma and early Feno level reductions by Ian D. Pavord, MD, Michael E. Wechsler, MD, William W. Busse, MD, Christian Domingo, MD, Changming Xia, PhD, Rebecca Gall, MD, Nami Pandit-Abid, PharmD, Juby A. Jacob-Nara, MD, DHSc, Amr Radwan, MBBChir, Paul J. Rowe, MD, Yamo Deniz, MD

Get full text